Cost effectiveness of proprotein convertase subtilisin/ kexin type 9 (PCSK9) inhibitors

The cost effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9-(PCSK9) inhibitors was a global concern, we here elaborate on the analysis done in different countries and explore the unseen part of such analysis. A guideline-based approach with careful monitoring the use and delivered price will minimize the concern regarding cost effectiveness of PCSK9 inhibitors.